Latest Capital Management News

Careteq Limited reports a significant reduction in operating cash outflow and modest revenue growth for FY25, while facing delays in its key platform integration and a dispute with the ATO over R&D claims.

Paradigm Biopharmaceuticals has advanced its global Phase 3 trial for knee osteoarthritis pain with active patient recruitment in Australia and the US, backed by a $41.2 million convertible note facility. The company also expanded its osteoarthritis portfolio through the acquisition of Proteobioactives and the Pentacoxib™ oral therapy.

Mach7 Technologies closes FY25 with solid recurring revenue growth, positive cash flow, and a refreshed leadership team focused on innovation and customer value.

Murray Cod Australia reports a near tripling of biomass and strong sales growth in Q4 FY25, while advancing key certifications and expanding market reach.

Ramelius Resources delivered record FY25 gold production and free cash flow, surpassing guidance, while finalising its transformative acquisition of Spartan Resources. The company is ramping up exploration and integration efforts to target half a million ounces annual production by FY30.

Epsilon Healthcare has emerged from voluntary administration with a stronger balance sheet, securing refinancing and preparing to launch its new pharmacy platform. Operational stability and strategic initiatives signal a turning point for the healthcare group.

Kaiser Reef has completed a transformative acquisition of the Henty Gold Mine, backed by a $20.9 million capital raise, positioning the company for significant growth in Tasmania and Victoria.

WIN Metals Ltd has significantly expanded its Butchers Creek gold resource, boosting indicated ounces by 86% and advancing the project towards economic evaluation. Concurrent exploration successes and strategic asset sales underpin the company’s focused growth strategy.

Saferoads Holdings reports a $192k operating cash use impacted by strategic prepayments, completes its Road Safety Rentals asset sale, and maintains strong cash reserves after paying a substantial dividend.

TruScreen Group Limited has announced a placement of over 1.7 million shares to settle marketing invoices and provide an equity incentive to its CFO, signaling strategic capital management ahead of its next growth phase.

Bubs Australia Limited reports a strong FY25 with 29% revenue growth to $102.5 million, positive EBITDA turnaround, and sustained cash flow improvements. The company also advances its US market ambitions with a key FDA submission underway.

Pureprofile Limited reported record FY25 results, achieving 19% revenue growth and launching new AI-driven data solutions to fuel future expansion.